Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS-ESMO initiative endorsed by CSCO, ISMPO, JS']JSMO, KSMO, MOS and SSO

被引：173

作者：

Chen, L-T ^{[1
,2
,3
]}

Martinelli, E. ^{[4
]}

Cheng, A-L ^{[5
,6
]}

Pentheroudakis, G. ^{[7
]}

Qin, S. ^{[8
]}

Bhattacharyya, G. S. ^{[9
]}

Ikeda, M. ^{[10
]}

Lim, H-Y ^{[11
]}

Ho, G. F. ^{[12
]}

Choo, S. P. ^{[13
,14
]}

Ren, Z. ^{[15
]}

Malhotra, H. ^{[16
]}

Ueno, M. ^{[17
]}

Ryoo, B-Y ^{[18
]}

Kiang, T. C. ^{[19
]}

Tai, D. ^{[20
]}

Vogel, A. ^{[21
]}

Cervantes, A. ^{[22
]}

Lu, S-N ^{[23
]}

Yen, C-J ^{[2
]}

Huang, Y-H ^{[24
,25
]}

Chen, S-C ^{[26
]}

Hsu, C. ^{[6
,27
]}

Shen, Y-C ^{[5
]}

Tabernero, J. ^{[28
,29
]}

Yen, Y. ^{[30
]}

Hsu, C-H ^{[5
,27
]}

Yoshino, T. ^{[10
]}

Douillard, J-Y ^{[31
]}

机构：

[1] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan

[2] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan, Taiwan

[3] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan

[4] Univ Campania L Vanvitelli, Dept Clin & Expt Med F Magrassi Med Oncol, Naples, Italy

[5] Natl Taiwan Univ, Canc Ctr, Dept Med Oncol, Taipei, Taiwan

[6] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan

[7] Univ Ioannina, Dept Med Oncol, Ioannina, Greece

[8] Jinling Hosp, Chinese PLA Canc Ctr, Nanjing, Peoples R China

[9] Salt Lake City Med Ctr, Kolkata, India

[10] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan

[11] Sungkyunkwan Univ, Samsung Med Ctr, Div Hematol Oncol, Seoul, South Korea

[12] Univ Malaya, Fac Med, Kuala Lumpur, Malaysia

[13] Curie Oncol, Singapore, Singapore

[14] Natl Canc Ctr Singapore, Singapore, Singapore

[15] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China

[16] Mahatma Gandhi Med Coll Hosp, Sri Ram Canc Ctr, Dept Med Oncol, Jaipur, Rajasthan, India

[17] Kanagawa Canc Ctr, Hepatobiliary & Pancreat Med Oncol Div, Dept Gastroenterol, Yokohama, Kanagawa, Japan

[18] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea

[19] Hosp Umum Sarawak, Sarawak, Malaysia

[20] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore

[21] Med Sch Hannover, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany

[22] Univ Valencia, INCLIVIA, Inst Hlth Res, Dept Med Oncol,CIBERONC, Valencia, Spain

[23] Chiayi Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Chiayi, Taiwan

[24] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan

[25] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol & Hepatol, Taipei, Taiwan

[26] Taipei Vet Gen Hosp, Dept Oncol, Div Med Oncol, Taipei, Taiwan

[27] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei, Taiwan

[28] Vall dHebron Univ Hosp, Med Oncol Dept, Barcelona, Spain

[29] UVic, IOB Quiron, Inst Oncol VHIO, Barcelona, Spain

[30] Taipei Med Univ, Taipei, Taiwan

[31] ESMO, Lugano, Switzerland

来源：

ANNALS OF ONCOLOGY | 2020年 / 31卷 / 03期

关键词：

consensus; ESMO guidelines; HCC; hepatocellular carcinoma; Pan-Asian; RANDOMIZED PHASE-III; ARTERIAL INFUSION CHEMOTHERAPY; PRIMARY LIVER-CANCER; HEPATITIS-B-VIRUS; INTERNAL RADIATION-THERAPY; TRANSARTERIAL CHEMOEMBOLIZATION; COST-EFFECTIVENESS; CONTROLLED-TRIAL; DOUBLE-BLIND; HEPATOBILIARY PHASE;

D O I：

10.1016/j.annonc.2019.12.001

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of hepatocellular carcinoma (HCC) was published in 2018, and covered the diagnosis, management, treatment and follow-up of early, intermediate and advanced disease. At the ESMO Asia Meeting in November 2018 it was decided by both the ESMO and the Taiwan Oncology Society (TOS) to convene a special guidelines meeting immediately after the Taiwan Joint Cancer Conference (TJCC) in May 2019 in Taipei. The aim was to adapt the ESMO 2018 guidelines to take into account both the ethnic and the geographic differences in practice associated with the treatment of HCC in Asian patients. These guidelines represent the consensus opinions reached by experts in the treatment of patients with intermediate and advanced/relapsed HCC representing the oncology societies of Taiwan (TOS), China (CSCO), India (ISMPO) Japan (JSMO), Korea (KSMO), Malaysia (MOS) and Singapore (SSO). The voting was based on scientific evidence, and was independent of the current treatment practices, the drug availability and reimbursement situations in the individual participating Asian countries.

引用

页码：334 / 351

页数：18

共 122 条

[1] Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: Results from the randomized phase III CELESTIAL trial. [J].

Abou-Alfa, Ghassan K. ;

Meyer, Tim ;

Cheng, Ann-Lii ;

El-Khoueiry, Anthony B. ;

Rimassa, Lorenza ;

Ryoo, Baek-Yeol ;

Cicin, Irfan ;

Merle, Philippe ;

Park, Joong-Won ;

Blanc, Jean-Frederic ;

Bolondi, Luigi ;

Klumpen, Heinz Josef ;

Chan, Stephen Lam ;

Dadduzio, Vincenzo ;

Hessel, Colin ;

Borgman-Hagey, Anne E. ;

Schwab, Gisela ;

Kelley, Robin Kate .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)

[2]

[Anonymous], 2019, ESMO ASIA

[3] Hepatocellular carcinoma in Asia: Prevention strategy and planning [J].

Ashtari, Sara ;

Pourhoseingholi, Mohamad Amin ;

Sharifian, Afsaneh ;

Zali, Mohamad Reza .

WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (12) :1708-1717

[4] Expanding the Baveno VI Criteria for the Screening of Varices in Patients With CompensatedAdvancedChronicLiverDisease [J].

Augustin, Salvador ;

Pons, Monica ;

Maurice, James B. ;

Bureau, Christophe ;

Stefanescu, Horia ;

Ney, Michel ;

Blasco, Helene ;

Procopet, Bogdan ;

Tsochatzis, Emmanuel ;

Westbrook, Rachel H. ;

Bosch, Jaime ;

Berzigotti, Annalisa ;

Abraldes, Juan G. ;

Genesca, Joan .

HEPATOLOGY, 2017, 66 (06) :1980-1988

[5] Contrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted livers [J].

Bartolozzi, Carlo ;

Battaglia, Valentina ;

Bargellini, Irene ;

Bozzi, Elena ;

Campani, Daniela ;

Pollina, Luca Emanuele ;

Filipponi, Franco .

ABDOMINAL IMAGING, 2013, 38 (02) :290-296

[6] Elastography, Spleen Size, and Platelet Count Identify Portal Hypertension in Patients With Compensated Cirrhosis [J].

Berzigotti, Annalisa ;

Seijo, Susana ;

Arena, Umberto ;

Abraldes, Juan G. ;

Vizzutti, Francesco ;

Garcia-Pagan, Juan Carlos ;

Pinzani, Massimo ;

Bosch, Jaime .

GASTROENTEROLOGY, 2013, 144 (01) :102-U206

[7] Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience [J].

Bettinger, Dominik ;

Spode, Renan ;

Glaser, Nicolas ;

Buettner, Nico ;

Boettler, Tobias ;

Neumann-Haefelin, Christoph ;

Brunner, Thomas Baptist ;

Gkika, Eleni ;

Maruschke, Lars ;

Thimme, Robert ;

Schultheiss, Michael .

BMC GASTROENTEROLOGY, 2017, 17

[8] Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and 18F-FDG PET/CT in patients on waiting-list for liver transplantation [J].

Boussouar, Samia ;

Itti, Emmanuel ;

Lin, Shih-Jui ;

Decaens, Thomas ;

Evangelista, Eva ;

Chiaradia, Melanie ;

Chalaye, Julia ;

Baranes, Laurence ;

Calderaro, Julien ;

Laurent, Alexis ;

Pigneur, Frederic ;

Duvoux, Christophe ;

Azoulay, Daniel ;

Costentin, Charlotte ;

Rahmouni, Alain ;

Luciani, Alain .

CANCER IMAGING, 2016, 16

[9]

Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]

[10] Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone [J].

Brown, Karen T. ;

Do, Richard K. ;

Gonen, Mithat ;

Covey, Anne M. ;

Getrajdman, George I. ;

Sofocleous, Constantinos T. ;

Jarnagin, William R. ;

D'Angelica, Michael I. ;

Allen, Peter J. ;

Erinjeri, Joseph P. ;

Brody, Lynn A. ;

O'Neill, Gerald P. ;

Johnson, Kristian N. ;

Garcia, Alessandra R. ;

Beattie, Christopher ;

Zhao, Binsheng ;

Solomon, Stephen B. ;

Schwartz, Lawrence H. ;

DeMatteo, Ronald ;

Abou-Alfa, Ghassan K. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (17) :2046-+

← 1 2 3 4 5 6 7 8 9 10 →